Vetoquinol Review 2026: Pharma Rigor, Corporate Silence

Vetoquinol Pros and Cons

Pros

• Audited structural quality: NASC membership with an independent audit, an explicit cGMP manufacturing statement, and participation in the NAERS adverse-event reporting system — the only brand in our 20-brand report to surface adverse-event infrastructure.
• Flexadin Advanced publishes real active math: UC-II brand collagen listed as chicken cartilage yielding 10 mg of active undenatured Type II collagen per 40 mg, with defined serving sizes and complete inactive lists.
• The Flexadin pages cite an attributed, dated study — D'Altilio et al., 2007, a 120-day comparison of 10 mg UC-II against 2,000 mg glucosamine + 1,600 mg chondroitin — and mark the headline comparative claim with a qualifying asterisk that resolves to it.
• Structure-function claim language throughout ("helps maintain joint function," "support a normal immune response").
• The backing of a global pharmaceutical parent with the regulatory apparatus that implies.

Cons

• No veterinarian, nutritionist, formulator, or scientific advisor is named anywhere on the site — expertise is conveyed entirely through "veterinarian recommended" framing and the vet-channel itself. For a company of this size, the silence is a choice.
• No public COA lookup, named testing laboratory, or contaminant/microbial/potency panel of any kind; manufacturing facilities are not named at facility, city, or state level.
• Label disclosure varies sharply: Triglyceride OMEGA reports fish-oil blend totals without per-active EPA/DHA amounts, and Zylkene gives capsule strengths without isolating the alpha-casozepine amount — the active the product is named for.
• Evidence discipline is one product deep: Flexadin's citation practice does not extend across the line.

The Pharma Pattern, in Both Directions

Vetoquinol's disclosure profile makes sense once you see the company behind it. A veterinary pharmaceutical multinational runs real quality infrastructure as a matter of regulatory survival — hence the audited NASC program, the cGMP statement, and NAERS adverse-event participation, which is genuine post-market safety infrastructure that no DTC brand in our report even mentions. When this company says its systems are rigorous, the corporate context makes that more credible than the same words from a three-year-old chew brand.

But pharma companies also default to institutional anonymity and channel-mediated evidence — and that transfers to the supplement line wholesale. Nobody is named: the About page describes an entity, not people. Nothing is documented for consumers: no COA, no lab, no facility identity, no panels. Like Nutramax, Vetoquinol assumes the veterinarian is your verification layer; unlike Nutramax, it doesn't publish much for the professional-curious shopper either.

Three Products, Three Disclosure Standards

Flexadin Advanced — the model. Active math done properly (40 mg UC-II yielding 10 mg active undenatured Type II collagen), defined servings, complete inactives, and a dated, attributed study behind the asterisked comparative claim. If the whole line looked like this, Vetoquinol would score twenty points higher.

Zylkene — the opacity. The calming line built on alpha-casozepine discloses capsule strengths without isolating how much alpha-casozepine is in them. Disclosing everything except the amount of the active the product is named for is the exact pattern our active-identity flag exists to catch.

Triglyceride OMEGA — the blend. Fish-oil totals without EPA/DHA splits — the two numbers any veterinarian dosing omega-3s actually needs.

How to verify Vetoquinol yourself: ask your veterinarian (the intended channel), or email Vetoquinol for (1) the COA for your lot with the lab named, (2) the alpha-casozepine amount per Zylkene capsule strength, and (3) EPA/DHA amounts for the OMEGA products. A pharma company has all three on file.

Public Transparency Score: 51/100 — With Category Context

Under the 2026 Brand Transparency Rubric, Vetoquinol USA earns a 51/100 Public Transparency Score — Disclosure Gaps (scored as of 2026-06-13). The score measures what a buyer can publicly verify before purchase — not effectiveness, safety, or quality — and for vet-channel companies it carries the same category context we apply to Nutramax: a brand whose disclosure routes through veterinary professionals will score below its institutional reputation on public checkability. With a pharma parent, the gap between internal rigor and public disclosure is probably the widest in our report.

The shape: manufacturing/quality systems (8) far ahead of everything else; claims disciplined (7); labels uneven (6); and expert transparency at 2 — no names at all, from a company employing many of the world's veterinary scientists.

Best fit: buyers whose veterinarian recommended a specific product — especially Flexadin, where the public disclosure actually supports the decision. Keep comparing if: you're shopping cold and need active amounts (Zylkene, OMEGA) or batch documents the public site doesn't offer.

Owner Reviews

The owner-review sample (167 items, checked 2026-06-21, low confidence) skews practical and mildly positive: owner-reported changes lead (37 — personal observations, not proof), serving-routine notes are prominent (32 — capsules and oil pumps take adjustment), with modest tolerance (7) and palatability (7) clusters and some retail shipping complaints (13). Pricing was not captured in our snapshot — Vetoquinol sells through veterinary and retail channels where prices vary by seller.

Where La Petite Labs Fits

It doesn't — and for the second vet-channel brand in a row, saying so plainly is the entire section. La Petite Labs sells no joint-collagen, calming, or fish-oil product; Flexadin, Zylkene, and Triglyceride OMEGA have no La Petite Labs counterpart, and this review makes no comparison. If your veterinarian recommended one of these products, that recommendation was made with access to evidence and adverse-event data this review cannot see, and it outranks any brand-published page — including this one.

What transfers from our work is the checklist, not a product: knowing to ask for the alpha-casozepine amount, the EPA/DHA split, and the lot COA turns a vet-channel purchase from trust into verification.

Final Verdict: Should You Buy Vetoquinol Products?

On a veterinarian's recommendation: yes, comfortably — the structural quality systems are real, the adverse-event infrastructure is unique in our report, and Flexadin in particular gives you public math to confirm the recommendation. Shopping cold: buy Flexadin on its merits if UC-II is your lane; make the company produce the numbers before buying Zylkene or the OMEGA line, because the labels don't give you what you'd need to compare. Either way, the professional channel is this brand's verification layer — use it.

FAQ

Is Vetoquinol legit?

Institutionally, among the most established in our report: the US arm of Vétoquinol S.A., a French veterinary pharmaceutical multinational, operating since 1994 with audited NASC membership and adverse-event reporting participation.

What is Flexadin Advanced?

Vetoquinol's UC-II joint line — and its best-disclosed product: 40 mg of UC-II brand collagen yielding 10 mg of active undenatured Type II collagen, with a cited 120-day study (D'Altilio et al., 2007) comparing it against glucosamine + chondroitin behind an asterisked claim.

How much alpha-casozepine is in Zylkene?

The public pages don't say — capsule strengths are given without isolating the signature active's amount. Ask Vetoquinol or your veterinarian for the per-capsule figure before comparing calming products.

Does Vetoquinol publish COAs or name a testing lab?

No. The NASC audit and cGMP statement cover systems, not batches — no COA, named laboratory, or lot lookup is public. Request your lot's certificate directly.

Is Vetoquinol vet recommended?

That framing appears throughout, and the vet channel is genuinely this company's home. No individual veterinarian is named anywhere on the consumer surface.

What is NAERS and why does it matter?

The adverse-event reporting system Vetoquinol participates in — post-market safety infrastructure that no other brand in our 20-brand report surfaces. It doesn't tell you about a specific batch, but it signals real pharmacovigilance habits.

Where are Vetoquinol products made?

In cGMP-following approved facilities per the NASC disclosure — with no facility, city, or state named publicly.

Does Triglyceride OMEGA disclose EPA and DHA?

No — blend totals only, without the per-active EPA/DHA amounts a dosing decision needs. Ask for the split.

Why does a pharma company score 51/100?

Because the score measures public checkability, and pharma disclosure culture routes through professionals and regulators rather than product pages. The internal rigor is likely high; the public artifacts are absent. Both things are true.

Is there a La Petite Labs alternative to Flexadin or Zylkene?

No. La Petite Labs sells no joint or calming product, and this review makes no comparison or substitution claim.

What should I verify before buying Vetoquinol?

Which product and strength your vet actually means; Flexadin's active math against the recommendation (it's public); the alpha-casozepine or EPA/DHA numbers for Zylkene/OMEGA (by request); and your lot's COA if batch documentation matters to you.